BlackRock Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

BlackRock Investment Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.35M	Buy	90,607 +577	+0.6%	+$8.1K	﹤0.01%	2489
2016 Q3	$1.13M	Buy	90,030 +8,827	+11%	+$88.6K	﹤0.01%	2587
2016 Q2	$731K	Buy	81,203 +7,116	+10%	+$69.7K	﹤0.01%	2841
2016 Q1	$734K	Buy	74,087 +1,894	+3%	+$19.4K	﹤0.01%	2688
2015 Q4	$830K	Buy	72,193 +994	+1%	+$12.3K	﹤0.01%	2728
2015 Q3	$961K	Buy	71,199 +854	+1%	+$11.6K	﹤0.01%	2629
2015 Q2	$974K	Buy	70,345 +22,027	+46%	+$298K	﹤0.01%	2780
2015 Q1	$680K	Buy	48,318 +10,556	+28%	+$144K	﹤0.01%	2793
2014 Q4	$514K	Buy	37,762 +134	+0.4%	+$1.83K	﹤0.01%	2994
2014 Q3	$575K	Sell	37,628 -19,829	-35%	-$304K	﹤0.01%	2896
2014 Q2	$967K	Sell	57,457 -5,149	-8%	-$92.7K	﹤0.01%	2632
2014 Q1	$1.26M	Buy	62,606 +470	+0.8%	+$10.2K	﹤0.01%	2351
2013 Q4	$1.2M	Buy	+62,136	New	+$1.1M	﹤0.01%	2368

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

BlackRock Investment Management's OXFD Position: Q4 2016 in Review

BlackRock Investment Management increased its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 0.64% in Q4 2016, buying an estimated $8.1K and bringing the position to 90,607 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2489.

BlackRock Investment Management first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.

BlackRock Investment Management held 90,607 shares of Oxford Immunotec Global PLC Ordinary Shares worth $1.35M as of Q4 2016.
BlackRock Investment Management bought 577 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2016, an estimated $8.1K.
Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2489 holding.
BlackRock Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 13 quarters since.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.